DEXTABS Trademark

Trademark Overview

On Thursday, September 5, 2024, a trademark application was filed for DEXTABS with the United States Patent and Trademark Office. The USPTO has given the DEXTABS trademark a serial number of 98735670. The federal status of this trademark filing is APPROVED FOR PUBLICATION as of Thursday, April 10, 2025. This trademark is owned by DXM Pharmaceutical, Inc.. The DEXTABS trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations, namely, over-the-counter cough suppressants; cough suppressants in tablet form.
dextabs

General Information

Serial Number98735670
Word MarkDEXTABS
Filing DateThursday, September 5, 2024
Status680 - APPROVED FOR PUBLICATION
Status DateThursday, April 10, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and Servicespharmaceutical preparations, namely, over-the-counter cough suppressants; cough suppressants in tablet form.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, September 5, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameDXM Pharmaceutical, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressKaty, TX 77494

Trademark Events

Event DateEvent Description
Thursday, September 5, 2024NEW APPLICATION ENTERED
Thursday, September 5, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, February 12, 2025ASSIGNED TO EXAMINER
Wednesday, February 12, 2025NON-FINAL ACTION E-MAILED
Wednesday, February 12, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, February 12, 2025NON-FINAL ACTION WRITTEN
Saturday, April 5, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, April 5, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, April 8, 2025NON-FINAL ACTION WRITTEN
Tuesday, April 8, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, April 9, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 9, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, April 9, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, April 10, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, April 8, 2025NON-FINAL ACTION E-MAILED
Saturday, April 5, 2025TEAS/EMAIL CORRESPONDENCE ENTERED

Related Keywords

dextabs cough suppressants form tablet counter preparations namely over pharmaceutical